Fatty links between multisystem proteinopathy and Small VCP-Interacting Protein
F. Ramzan, F. Abrar, A. Kumar, L. M. Q. Liao, Z. E. Campbell, R. V. Gray, O. Akanni, C. M. Guyn, D. D. O. Martin
Abstract
Multisystem proteinopathy (MSP) is a rare dominantly-inherited disorder that includes a cluster of diseases, including frontotemporal dementia, inclusion body myopathy, and Pagets disease of bone. MSP is caused by mutations in the gene encoding Valosin-Containing Protein (VCP). Patients with the same mutation, even within the same family, can present with a different combination of any or all of the above diseases, along with amyotrophic lateral sclerosis (ALS). The pleiotropic effects may be linked to the greater than 50 VCP cofactors that direct VCPs many roles in the cell. Small VCP-Interacting Protein (SVIP) is a small protein that directs VCP to autophagosomes and lysosomes. We found that SVIP directs VCP localization to autophagosomes in an acylation-dependent manner. We demonstrate that SVIP is myristoylated at glycine 2 and palmitoylated at cysteines 4 and 7. Acylation of SVIP is required to mediate cell death in the presence of the MSP-associated VCP variant (R155H-VCP), whereas blocking SVIP myristoylation prevents cytotoxicity. Therefore, SVIP acylation may present a novel target in MSP.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ASPL-driven subunit exchange remodels VCP/p97 hexamers and is impaired by a multisystem proteinopathy mutation
Jingxuan Tang, Laxmikanta Khamari, … Nils G. Walter·bioRxiv·May 8, 2026
- Antisense oligonucleotides targeting Valosin-containing protein improve muscle pathology and molecular defects in cell and mouse models of multisystem proteinopathy.
Pallabi Pal, Michele Carrer, … Virginia E. Kimonis·bioRxiv·Jul 25, 2025
- Novel VCP activator reverses multisystem proteinopathy nuclear proteostasis defects and enhances TDP-43 aggregate clearance
Jessica M. Phan, Benjamin C. Creekmore, … Edward B. Lee·bioRxiv·Mar 15, 2023
- A Novel Autosomal Dominant Childhood-Onset Disorder Associated with Pathogenic Variants in VCP
Annelise Yoo Mah-Som, Jil Daw, … Marwan S. Shinawi·medRxiv·Jun 19, 2023
- Utilization of CoRDS Registry to Monitor Quality of Life in Patients with VCP Multisystem Proteinopathy
Eiman Abdoalsadig, Merwa Hamid, … Virginia E. Kimonis·Orphanet Journal of Rare DiseasesPeer-reviewed·Apr 14, 2025
- VCP is a critical component for TDP-43 disaggregase activity in skeletal muscle
Eileen M. Lynch, Sara K. Pittman, … Conrad Chris Weihl·bioRxiv·Sep 21, 2026